Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROONE MEDICAL TECH

0.5649
-0.0162-2.79%
Post-market: 0.59530.0304+5.38%19:20 EDT
Volume:142.54K
Turnover:82.45K
Market Cap:28.14M
PE:-2.24
High:0.5999
Open:0.5700
Low:0.5600
Close:0.5811
Loading ...

Neuroone Medical Technologies Corp: Confirms No Material Impact From Global Tariffs

THOMSON REUTERS
·
16 Apr

NeuroOne® OneRF® Technology Success Story Featured on Fox News

GlobeNewswire
·
14 Apr

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Benzinga
·
05 Apr

NeuroOne Medical prices 16M shares at 50c in underwritten public offering

TIPRANKS
·
04 Apr

Neuroone Medical Technologies Corp - Prices Public Offering of 16 Mln Shares at $0.50 per Share

THOMSON REUTERS
·
04 Apr

Neuroone Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

THOMSON REUTERS
·
04 Apr

US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

Benzinga
·
04 Apr

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday

Benzinga
·
04 Apr

NeuroOne Medical Technologies Starts Proposed Public Offering of Shares; Shares Slump After Hours

MT Newswires Live
·
04 Apr

BRIEF-Neuroone Medical Technologies Corporation Announces Proposed Public Offering Of Common Stock

Reuters
·
04 Apr

Neuroone Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
04 Apr

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

GlobeNewswire
·
19 Mar

Neuroone CEO Joins Today’s Marketplace to Discuss the Latest Treatments for Epilepsy

THOMSON REUTERS
·
18 Mar

NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ...

GuruFocus.com
·
13 Feb

NeuroOne Medical Tech Q1 EPS $0.06 Up From $(0.14) YoY, Sales $3.27M Up From $977.65K YoY

Benzinga
·
12 Feb

Neuroone Medical Technologies Corp Qtrly EPS $0.06

THOMSON REUTERS
·
12 Feb

Neuroone Medical Technologies Corp: Reaffirms Its Fiscal Year 2025 Guidance of Product Revenue, Which Excludes License Revenue

THOMSON REUTERS
·
12 Feb

Neuroone Medical Technologies Q1 Operating Expenses USD 3.2 Million

THOMSON REUTERS
·
12 Feb

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
12 Feb

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

GlobeNewswire
·
06 Feb